Fluarix Tetra

Fluarix Tetra

vaccine, influenza

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Inactivated quadrivalent influenza vaccine (split virion)
Indications/Uses
Active immunisation of adults & childn from 6 mth for prevention of influenza disease caused by influenza virus types A & B.
Dosage/Direction for Use
0.5 mL single IM inj. Childn 6 mth to <9 yr not previously vaccinated against influenza 2nd dose to be given after at least 4 wk interval.
Contraindications
Hypersensitivity after previous inj or to influenza vaccines.
Special Precautions
Not to be administered intravascularly. Not to be used against all possible strains of influenza virus. Postpone vaccination in patients suffering from acute severe febrile illness. Thrombocytopenia, coagulation disorder; syncope. Immunodeficiency or concomitant use w/ immunosuppressives. Pregnancy & lactation. Childn <6 mth.
Adverse Reactions
Inj site pain, redness, swelling; fever. Adults & childn 6 to <18 yr: Myalgia; fatigue. Headache; GI symptoms eg, nausea, vomiting, diarrhoea, abdominal pain; arthralgia; shivering. Adults & childn 3 to <18 yr: Inj site induration. Adults: Sweating. Childn 6 mth to <6 yr: Loss of appetite; irritability/fussiness; drowsiness.
ATC Classification
J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.
Presentation/Packing
Form
Fluarix Tetra vaccine (inj) 0.5 mL
Packing/Price
10 × 1's;1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in